Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
Oncotarget
.
2020 Oct 13;11(41):3749-3750.
doi: 10.18632/oncotarget.27755.
Authors
Suyoun Chung
1
,
Kyoko Kijima
1
,
Aiko Kudo
1
,
Yoshiko Fujisawa
1
,
Yosuke Harada
1
,
Akiko Taira
1
,
Naofumi Takamatsu
1
,
Takashi Miyamoto
1
,
Yo Matsuo
1
,
Yusuke Nakamura
2
Affiliations
1
OncoTherapy Science, Inc., Kawasaki, Kanagawa, Japan.
2
Department of Medicine and Surgery, The University of Chicago, Chicago, IL, USA.
PMID:
33110482
PMCID:
PMC7566805
DOI:
10.18632/oncotarget.27755
Abstract
[This corrects the article DOI: 10.18632/oncotarget.7685.].
Publication types
Published Erratum